To further confirm the involvement of JAK2/STAT3 pathway in carboplatin resistance in RB cells, Y-79/CR cells were first transfected with or without STAT3 siRNA or NF-κB siRNA, and then cell sensitivity to carboplatin was determined. The gene discussed is JAK2; the disease is retinoblastoma.